| 2024-11-08 | -2.06 % |
|
| 2024-10-31 | -0.58 % |
|
| 2024-10-29 | -1.03 % |
|
| 2024-10-28 | +1.59 % |
|
| 2024-10-23 | -1.36 % |
|
| 2024-10-22 | -0.56 % |
|
| 2024-10-18 | +1 % |
|
| 2024-10-16 | +0.91 % |
|
| 2024-10-14 | +0.68 % |
|
| 2024-10-10 | -0.67 % |
|
| 2024-10-08 | +1 % |
|
| 2024-10-04 | +0.03 % |
|
| 2024-10-03 | -0.94 % |
|
| 2024-09-30 | -0.44 % |
|
| 2024-09-27 | +3.33 % |
|
| 2024-09-25 | -1.23 % |
|
| 2024-09-24 | -1.3 % |
|
| 2024-08-14 | -1.34 % |
|
| 2024-08-07 | +2.89 % |
|
| 2024-08-06 | -8.11 % |
|
| 2024-07-22 | +0.87 % |
|
| 2024-07-17 | +5.37 % |
|
| 2024-07-15 | +1.06 % |
|
| 2024-07-11 | +1.42 % |
|
| 2024-07-10 | -0.39 % |
|
| 2024-06-10 | -1.59 % |
|
| 2024-05-31 | +0.13 % |
- Summary: Henry Schein Medical, a division of Henry Schein, Inc. (Nasdaq: HSIC), showcased its EMS products and services supporting the future of the industry at a conference, which likely contributed to the stock going up by 0.13%.
Reason for Stock Increase: The Company highlighted its capabilities for mobile integrated health, community paramedicine, and other community-based models of care, emphasizing its commitment to advancing technologies and products in the field of EMS, which likely led to the positive market response reflected in the stock increase.
- The article discusses Henry Schein, Inc. (HSIC) stock and its recent performance, which was up by 0.13%. The stock is currently rated as "Hold" by eleven brokerages, with varying buy and hold recommendations. The stock price went up likely due to the company's recent earnings report, where they beat consensus estimates, posting earnings per share of $1.10 for the quarter and positive revenue growth, leading analysts to predict a positive earnings per share for the current year.
- Nomura Asset Management and other institutional investors reduced their holdings in Henry Schein, Inc. (HSIC) during the 4th quarter, with the stock rising by 0.13% last night, likely due to positive quarterly earnings release beating analysts' estimates, increased positions by Everett Harris & Co. CA, and other financial firms, and favorable ratings and target price adjustments by various analysts.
|
| 2024-05-21 | -0.3 % |
|
| 2024-05-17 | +0.36 % |
|
